vimarsana.com
Home
Live Updates
Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications : comparemela.com
Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications
MILAN, Italy and NEW YORK, April 03, 2023 -- Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide... | April 3, 2023
Related Keywords
Milan ,
Lombardia ,
Italy ,
Italian ,
Luigi Naldini ,
Pierluigi Paracchi ,
Mary Ann Chang ,
Tiziana Pollio ,
Exchange Commission ,
Globenewswire Inc ,
Ospedale San Raffaele ,
Chief Executive Officer ,
Golden Power Regulation ,
Glioblastoma Multiforme ,
Securities Litigation Reform Act ,
Annual Report ,
Ann Chang ,
Genenta Sciences Pa Stock Exchange ,
News ,
Information ,
Press Release ,
End ,
Few ,
Pril ,
023 ,
Genenta ,
Science ,
Company ,
Developing ,
Platform ,
Harnessing ,
The ,
Tower ,
F ,
Ematopoietic ,
Item ,
Cells ,
O Gnta Us36870w1009 ,
comparemela.com © 2020. All Rights Reserved.